(Q39824174)

14 September 2017

title

Prevalence of monoclonal gammopathy of undetermined significance: study of 52,802 persons in Nagasaki City, Japan (English)

1 reference

14 September 2017

1 reference

Masako Iwanaga

1

1 reference

14 September 2017

Masuko Tagawa

2

1 reference

14 September 2017

Kunihiro Tsukasaki

3

1 reference

14 September 2017

Shimera Kamihira

4

1 reference

14 September 2017

Masao Tomonaga

5

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 December 2007

1 reference

14 September 2017

1 reference

14 September 2017

volume

82

1 reference

14 September 2017

issue

12

1 reference

14 September 2017

page(s)

1474-1479

1 reference

Monoclonal gammopathy of undetermined significance. Natural history in 241 cases

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961090-2

"Benign" monoclonal gammopathy--after 20 to 35 years of follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961090-2

A long-term study of prognosis in monoclonal gammopathy of undetermined significance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961090-2

Monoclonal gammopathies in the adult population of Finistère, France

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961090-2

A 20-year follow-up study of 64 subjects with M-components

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961090-2

Monoclonal gammopathy in Iceland: a population-based registry and follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961090-2

Monoclonal gammopathy of undetermined significance (MGUS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961090-2

Incidence and evolution of monoclonal gammopathy of undetermined significance (MGUS) in Greece.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961090-2

Prevalence of monoclonal gammopathy of undetermined significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961090-2

Racial differences in the prevalence of monoclonal gammopathy in a community-based sample of the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961090-2

Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961090-2

A comparative study of monoclonal gammopathies and immunoglobulin levels in Japanese and United States elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961090-2

Myeloma aetiology and epidemiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961090-2

Frequency of pathological proteins (M-components) om 6,995 sera from an adult population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961090-2

10.1016/S0025-6196(11)61090-2

7 January 2021

Identifiers

DOI

1 reference

14 September 2017

1 reference